Enzo Biochem Inc. (ENZ) Shares Down 1.2%
Enzo Biochem Inc. (NYSE:ENZ)’s share price dropped 1.2% during mid-day trading on Friday . The stock traded as low as $5.87 and last traded at $5.92, with a volume of 187,143 shares changing hands. The stock had previously closed at $5.99.
Separately, Zacks Investment Research upgraded Enzo Biochem from a “sell” rating to a “hold” rating in a research report on Tuesday, May 24th.
The stock’s 50-day moving average is $5.97 and its 200 day moving average is $5.03. The company has a market cap of $274.81 million and a PE ratio of 15.55.
Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings data on Wednesday, June 8th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. During the same period in the previous year, the company earned ($0.07) earnings per share. The firm earned $18.16 million during the quarter, compared to analysts’ expectations of $24.50 million. On average, equities analysts expect that Enzo Biochem Inc. will post ($0.23) earnings per share for the current fiscal year.
Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.